Table 4.

Antimicrobial resistance patterns identified in Staphylococcus isolates from cat specimens tested at an academic veterinary hospital laboratory, 2007–2012

	Antimicrobial Resistance	Multidrug Resistance	B-Lactam resistance	Resistance patterns
Species	Percent (n/N)	Percent (n/N)	Percent (n/N)
S. aureus	85.7 (6/7)	42.9 (3/7)	0	AMP (1), AMP PEN (1), AMP PEN LIN (1), AMP PEN CLI LIN (1), AMP PEN CHL LIN (1), AMP SP KAN CLI LIN (1)
S. felis	0 (0/2)	0	0
S. intermedius group	52.9 (9/17)	11.8 (2/17)	5.9 (1/17)	PEN (1), KAN (1), CLI LIN (3), SP LIN (1), AMP PEN SP (1), ENR LIN OR TYL (1), AMP CEF GEN PEN SP CEF KAN OR SU (1)
S. simulans	0 (0/2)	0	0
S. spp.	90.0 (9/10)	30.0 (3/10)	0	CLI (2), LIN (1), CHL CLI (1), AMP PEN (1), CLI LIN OR (1), AMP AMP DOX ENR PEN CLI (1), AMP PEN CLI (1), AMP ENR PEN CLI LIN TYL (1),

n number of resistant samples, N number of samples tested, AMP ampicillin, CEF Ceftiofur, ENR Enrofloxacin, GEN Gentamicin, PEN PenicillinG, SP Sulpha/Trimethroprim, CHL Chloramphenicol, KAN Kanamycin, CLI Clindamycin/Lincomycin, AMI Amikacin, DOX Doxycycline, LIN Lincospectin, ORB Orbifloxacin, SU Amoxicillin/Clavulanic acid, TYL Tylosin